DISPROPORTIONALITY ANALYSIS FOR PHARMACOVIGILANCE OF MEDICAL DEVICE RELATED ADVERSE EVENTS REPORTED TO THE FDA

被引：0
|
作者：
Duggirala, H. J. [1 ]
Herz, N. D. [1 ]
Canos, D. A. [1 ]
Sullivan, R. [1 ]
Schaaf, Richard [1 ]
Pinnow, E. [1 ]
Marinac-Dabic, D. [1 ]
机构：
[1] Ctr Devices & Radiol Hlth Food & Drug Adm, Silver Spring, MD 20993 USA
来源：
AMERICAN JOURNAL OF EPIDEMIOLOGY | 2011年 / 173卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：S131 / S131
页数：1
相关论文
共 50 条
  • [21] A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS)
    Shu-peng Zou
    Hai-yun Yang
    Meng-ling Ouyang
    Qian Cheng
    Xuan Shi
    Ming-hui Sun
    BMC Pharmacology and Toxicology, 24
  • [22] Novel adverse events of blonanserin: a disproportionality analysis in the FDA Adverse Event Reporting System database
    Subeesh, Viswam
    Singh, Hemendra
    Maheswari, Eswaran
    Beulah, Thomas
    MINERVA PSICHIATRICA, 2018, 59 (02): : 105 - 110
  • [23] CLOZAPINE ASSOCIATED CARDIAC ADVERSE EVENTS: A REAL-WORLD PHARMACOVIGILANCE AND DISPROPORTIONALITY ANALYSIS
    Thotamgari, Sahith Reddy
    Dhaliwal, Lovekirat
    Bath, Anandbir
    Brar, Vijaywant
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 334 - 334
  • [24] Disproportionality analysis of upadacitinib-related adverse events in inflammatory bowel disease using the FDA adverse event reporting system
    Wang, Shiyi
    Wang, Xiaojian
    Ding, Jing
    Zhang, Xudong
    Zhu, Hongmei
    Fan, Yihong
    Sun, Changbo
    FRONTIERS IN PHARMACOLOGY, 2025, 16
  • [25] A pharmacovigilance analysis of FDA adverse event reporting system events for romosozumab
    Chen, Zepeng
    Li, Ming
    Li, Shuzhen
    Li, Yuxi
    Wu, Junyan
    Qiu, Kaifeng
    Yu, Xiaoxia
    Huang, Lin
    Chen, Guanghui
    EXPERT OPINION ON DRUG SAFETY, 2023, 22 (04) : 339 - 342
  • [26] A pharmacovigilance analysis of abrocitinib-related skin adverse events based on the FDA Adverse Event Reporting System (FAERS)
    Huang, Min
    Li, Peng
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2025, 317 (01)
  • [27] Analysis of Reported Adverse Events Related to the Use of the Through-The-Scope Endoscopic Suturing Device: An FDA MAUDE Database Study
    Ismail, Abdellatif
    Elawad, Ayman
    Mohammed, Shaikhoon S.
    Awadalla, Mohanad
    Mohammed, Elmkdad E.
    Aloum, Khalid
    Abosheaishaa, Hazem
    Wilson, Natalie
    Herman, Tessa
    Abdalla, Monzer
    Ahmed, Khalid
    Abdallah, Mohamed
    Bilal, Mohammad
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S599 - S599
  • [28] Novel Adverse Events of Bevacizumab in the US FDA Adverse Event Reporting System DatabaseA Disproportionality Analysis
    Behrooz K. Shamloo
    Pankdeep Chhabra
    Andrew N. Freedman
    Arnold Potosky
    Jennifer Malin
    Sheila Weiss Smith
    Drug Safety, 2012, 35 : 507 - 518
  • [29] A disproportionality analysis of adverse events associated with loop diuretics in the FDA Adverse Event Reporting System (FAERS)
    Xue, Zehu
    Liu, Xi
    Liu, Qifeng
    Yang, Xiuming
    Yu, Lixia
    BMC PHARMACOLOGY & TOXICOLOGY, 2025, 26 (01):
  • [30] Cardiovascular adverse events associated with parp inhibitors: A disproportionality analysis of FDA adverse event reporting system
    Viswam, Subeesh Kulangara
    Kheterpal, Aarushi
    Dhas, Ashwin
    Zeba, Zeba
    Shettigar, Amrutha
    Lukose, Lipin
    Kaur, Gursimran
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 452 - 452
12345